Package 69097-503-31

{"route": ["NASAL"], "spl_id": "68a5f507-1f3a-412d-8321-1e8d74cc31bc", "openfda": {"unii": ["81AXN7R2QT"], "rxcui": ["861668"], "spl_set_id": ["1ecb2311-eee3-4230-a019-a3496308cff1"], "manufacturer_name": ["Cipla USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "8 VIAL in 1 KIT (69097-503-27)  / 1 mL in 1 VIAL", "package_ndc": "69097-503-27", "marketing_start_date": "20200523"}, {"sample": false, "description": "1 VIAL in 1 KIT (69097-503-31)  / 1 mL in 1 VIAL", "package_ndc": "69097-503-31", "marketing_start_date": "20200523"}], "brand_name": "Dihydroergotamine Mesylate Nasal", "product_id": "69097-503_68a5f507-1f3a-412d-8321-1e8d74cc31bc", "dosage_form": "SPRAY, METERED", "pharm_class": ["Ergotamine Derivative [EPC]", "Ergotamines [CS]"], "product_ndc": "69097-503", "generic_name": "Dihydroergotamine Mesylate Nasal", "labeler_name": "Cipla USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Dihydroergotamine Mesylate Nasal", "active_ingredients": [{"name": "DIHYDROERGOTAMINE MESYLATE", "strength": "4 mg/mL"}], "application_number": "ANDA212907", "marketing_category": "ANDA", "marketing_start_date": "20200523", "listing_expiration_date": "20261231"}